Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Anti-Cancer Agents in Medicinal Chemistry
|
February 2, 2012
Molecular imaging of cancer with radiolabeled peptides and PET
Amy L Vāvere, Raffaella Rossin
Nuclear Medicine and Biology
|
March 22, 2008
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
Amy L Vāvere, Jason S Lewis
Dalton Transactions (Cambridge, England : 2003)
|
November 10, 2007
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia
Amy L Vāvere, Jason S Lewis
Seminars in Nuclear Medicine
|
August 23, 2017
Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook
Amy L Vāvere, Peter J H Scott
Nuclear Medicine and Biology
|
February 22, 2005
Production, processing and small animal PET imaging of titanium-45
Amy L Vāvere, Richard Laforest, Michael J Welch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2008
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L Vāvere, Steven J Kridel, Frances B Wheeler, et al.
Journal of Medicinal Chemistry
|
April 18, 2008
In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia
Paul D Bonnitcha, Amy L Vāvere, Jason S Lewis, et al.
Nuclear Medicine and Biology
|
November 14, 2007
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma
Lihui Wei, Yubin Miao, Fabio Gallazzi, et al.
ACS Chemical Neuroscience
|
August 28, 2015
A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use
Bao Hu, Amy L Vāvere, Kiel D Neumann, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
October 6, 2018
Improved, one-pot synthesis of 6-[<sup>18</sup> F]fluorodopamine and quality control testing for use in patients with neuroblastoma
Amy L Vāvere, Kiel D Neumann, Elizabeth R Butch, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Anti-Cancer Agents in Medicinal Chemistry
|
February 2, 2012
Molecular imaging of cancer with radiolabeled peptides and PET
Amy L Vāvere, Raffaella Rossin
Nuclear Medicine and Biology
|
March 22, 2008
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
Amy L Vāvere, Jason S Lewis
Dalton Transactions (Cambridge, England : 2003)
|
November 10, 2007
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia
Amy L Vāvere, Jason S Lewis
Seminars in Nuclear Medicine
|
August 23, 2017
Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook
Amy L Vāvere, Peter J H Scott
Nuclear Medicine and Biology
|
February 22, 2005
Production, processing and small animal PET imaging of titanium-45
Amy L Vāvere, Richard Laforest, Michael J Welch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2008
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L Vāvere, Steven J Kridel, Frances B Wheeler, et al.
Journal of Medicinal Chemistry
|
April 18, 2008
In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia
Paul D Bonnitcha, Amy L Vāvere, Jason S Lewis, et al.
Nuclear Medicine and Biology
|
November 14, 2007
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma
Lihui Wei, Yubin Miao, Fabio Gallazzi, et al.
ACS Chemical Neuroscience
|
August 28, 2015
A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use
Bao Hu, Amy L Vāvere, Kiel D Neumann, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
October 6, 2018
Improved, one-pot synthesis of 6-[<sup>18</sup> F]fluorodopamine and quality control testing for use in patients with neuroblastoma
Amy L Vāvere, Kiel D Neumann, Elizabeth R Butch, et al.
Page
of 2